allogenic adipose tissue-derived mesenchymal stem cells expanded / ANd&tAT - LARVOL DELTA

Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19 (clinicaltrials.gov) - P1/2 | N=26 | Completed | Sponsor: Andalusian Network for Design and Translation of Advanced Therapies | Active, not recruiting ➔ Completed | Trial completion date: Oct 2021 ➔ Dec 2021 | Trial primary completion date: Oct 2021 ➔ Dec 2021

Trial completion • Trial completion date • Trial primary completion date • Infectious Disease • Novel Coronavirus Disease • Pneumonia • Respiratory Diseases

Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19 (clinicaltrials.gov) - P1/2; N=26; Active, not recruiting; Sponsor: Andalusian Network for Design and Translation of Advanced Therapies; Recruiting ➔ Active, not recruiting

Clinical • Enrollment closed • Infectious Disease • Novel Coronavirus Disease • Pneumonia • Respiratory Diseases

Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19 (clinicaltrials.gov) - P1/2; N=26; Recruiting; Sponsor: Andalusian Network for Design and Translation of Advanced Therapies; Not yet recruiting ➔ Recruiting

Clinical • Enrollment open • Infectious Disease • Novel Coronavirus Disease • Pneumonia • Respiratory Diseases

Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19 (clinicaltrials.gov) - P1/2; N=26; Not yet recruiting; Sponsor: Andalusian Network for Design and Translation of Advanced Therapies

Clinical • New P1/2 trial